Related Experiment Video
Updated: May 23, 2026
19:15
Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
Published on: August 25, 2014
Neonatal pharmacology: extensive interindividual variability despite limited size
Summary
Neonatal drug therapy requires understanding developmental changes affecting drug processing (pharmacokinetics) and effects (pharmacodynamics). Integrated knowledge of clinical maturation is crucial for safe and effective medication use in newborns.
Area of Science:
- Developmental pharmacology
- Neonatal pharmacokinetics and pharmacodynamics
Background:
- Maturational changes significantly impact drug pharmacokinetics and pharmacodynamics, especially during the first year of life.
- Neonatal development is a dynamic process influencing drug disposition and response.
- Existing knowledge on developmental effects on drug pharmacodynamics in neonates is limited.
Purpose of the Study:
- To review and illustrate the covariates of pharmacokinetics and pharmacodynamics in neonates.
- To highlight the importance of developmental pharmacology in neonatal drug therapy.
Main Methods:
- Literature review of published studies on neonatal pharmacokinetics and pharmacodynamics.
- Analysis of factors influencing drug disposition and effects in neonates.
Main Results:
- Developmental changes in body composition, liver function, and renal function significantly alter drug pharmacokinetics.
- Age-dependent variations in receptor characteristics can influence drug pharmacodynamics.
- Integrated knowledge of clinical maturation is critical for optimizing neonatal drug therapy.
Conclusions:
- Safe and effective neonatal drug therapy necessitates a comprehensive understanding of developmental pharmacology.
- Further research is needed to fully elucidate the influence of ontogeny on drug pharmacodynamics in neonates.
Related Concept Videos
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
01:21Factors Affecting Drug Response: Overview
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
01:24Dosage Regimen: Individualization
Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...